CHARLOTTESVILLE, VA – November 7, 2006 – Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary approach to treat life-threatening diseases, today announced that it has appointed Matthew W. Hantzmon to the new position of Vice President, Business Development. Mr. Hantzmon, a senior executive with a successful record in medical technology and [...]

Human Testing Expected to Begin in Early 2007 CHARLOTTESVILLE, VA — October 17, 2006 — Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary mechanism of action to treat life-threatening diseases, today announced that it has completed all animal toxicology studies required by the U.S. Food and Drug Administration (FDA) to file [...]

CHARLOTTESVILLE, VA — June 6, 2006 — Diffusion Pharmaceuticals LLC, a drug discovery and development company, today announced that VaBIO, a membership organization that promotes the scientific and economic impact of the life sciences industry in the Commonwealth of Virginia, awarded it for the third year a $1,500 grant as part of the organization’s Summer [...]

Charlottesville, VA — February 21, 2006 — Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary mechanism of action to treat life-threatening diseases, today announced that toxicology testing of its lead drug, TSC, is currently underway at MPI Research, a leading provider of preclinical services. These studies are funded in part by [...]